Business Wire

Asana BioSciences Announces Achievement of Positive Results in the Clinical Proof of Concept Study in Atopic Dermatitis with ASN002, A Novel Oral JAK/SYK Inhibitor

LAWRENCEVILLE, N.J.--(BUSINESS WIRE)--Asana BioSciences, a clinical stage biopharmaceutical company, today announced that ASN002, its oral once daily dual JAK/SYK inhibitor, has achieved clinical ...
Investing

Citi raises target on Asana stock, maintains Neutral rating, awaits proof of AI upsell success

Looking ahead to fiscal year 2026, Asana's cross-selling of its new AI Studio product is anticipated to be a key focus. The company also aims to improve margins, with a target of achieving positive ...
CMS Wire

PageProof Launches a World-First Feature That Extends Proofing Experience for Marketing Teams and Creatives

PageProof is the only triple-layer encrypted online proofing solution that offers native integrations and support for all your design, communication, and project management tools like Adobe, Canva, ...
The Punch Newspapers

Work management platform to debut in Nigeria

An enterprise work management platform, Asana has said it would soon launch operations in Nigeria. A release from the firm stated that it would officially unveil operations at an event themed ...